BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 42 filers reported holding BOLT BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,213,630 | -18.8% | 1,166,952 | 0.0% | 0.98% | +2.9% |
| Q2 2023 | $1,493,699 | -7.9% | 1,166,952 | 0.0% | 0.96% | -13.5% |
| Q1 2023 | $1,622,063 | +6.9% | 1,166,952 | 0.0% | 1.10% | +5.6% |
| Q4 2022 | $1,517,038 | -12.2% | 1,166,952 | 0.0% | 1.04% | -5.2% |
| Q3 2022 | $1,727,000 | -27.5% | 1,166,952 | 0.0% | 1.10% | -32.6% |
| Q2 2022 | $2,381,000 | -25.5% | 1,166,952 | 0.0% | 1.64% | +7.8% |
| Q1 2022 | $3,197,000 | -44.1% | 1,166,952 | 0.0% | 1.52% | -10.4% |
| Q4 2021 | $5,718,000 | -61.3% | 1,166,952 | 0.0% | 1.69% | -64.2% |
| Q3 2021 | $14,762,000 | -18.2% | 1,166,952 | 0.0% | 4.72% | -15.7% |
| Q2 2021 | $18,041,000 | – | 1,166,952 | – | 5.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $29,242,000 | 11.52% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $18,041,000 | 5.60% |
| Novo Holdings A/S | 4,503,991 | $69,632,000 | 3.09% |
| Vivo Capital, LLC | 3,871,291 | $59,850,000 | 2.59% |
| Sofinnova Investments, Inc. | 2,754,437 | $42,584,000 | 2.45% |
| Ally Bridge Group (NY) LLC | 412,267 | $6,374,000 | 1.58% |
| Samsara BioCapital, LLC | 737,459 | $11,401,000 | 1.41% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $11,125,000 | 1.04% |
| RA Capital Management | 2,378,325 | $36,769,000 | 0.59% |
| Rock Springs Capital Management LP | 1,619,248 | $25,034,000 | 0.50% |